Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in J Virol Retrieve available abstracts of 60 articles: HTML format

Single Articles

March 2023
1. ZAIETS I, Gunewardena S, Menne S, Weinman SA, et al
   Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain Diverse RNA Types Produced by HBV Replication or Derived from Integrated HBV DNA.
   J Virol. 2023 Mar 6:e0195022. doi: 10.1128/jvi.01950.
   PubMed     Abstract available
   
   
   February 2023
2. SASAKI-TANAKA R, Masuzaki R, Okamoto H, Shibata T, et al
   Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
   J Virol. 2023 Feb 2:e0198722. doi: 10.1128/jvi.01987.
   PubMed     Abstract available
   
   
   January 2023
3. GLASSMAN KF, Brugge JS, Purchio AF, Kakach LT, et al
   Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human Being.
   J Virol. 2023;97:e0164322.
   PubMed    
   
   
   December 2022
4. KANAI T, Hu Z, Yang R, Wu W, et al
   Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis.
   J Virol. 2022 Dec 15:e0178822. doi: 10.1128/jvi.01788.
   PubMed     Abstract available
   
   
   
5. TANG L, An P, Zhao Q, Winkler CA, et al
   Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
   J Virol. 2022 Dec 15:e0126122. doi: 10.1128/jvi.01261.
   PubMed     Abstract available
   
   
   
6. PENG B, Jing Z, Zhou Z, Sun Y, et al
   Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
   J Virol. 2022 Dec 7:e0171722. doi: 10.1128/jvi.01717.
   PubMed     Abstract available
   
   
   November 2022
7. ZHAO Q, Chang J, Rijnbrand R, Lam AM, et al
   Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
   J Virol. 2022 Nov 30:e0115022. doi: 10.1128/jvi.01150.
   PubMed     Abstract available
   
   
   
8. CHEN Y, Wang B, Ou X, Wu Y, et al
   Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
   J Virol. 2022 Nov 17:e0102022. doi: 10.1128/jvi.01020.
   PubMed     Abstract available
   
   
   
9. SHIOTA T, Matsuda M, Zheng X, Nagata N, et al
   Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in Ifnar1(-/-) Mice.
   J Virol. 2022 Nov 10:e0149622. doi: 10.1128/jvi.01496.
   PubMed     Abstract available
   
   
   October 2022
10. SACCO MT, Bland KM, Horner SM
    WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
    J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
    PubMed     Abstract available
    
    
    
11. SCHWARZ MM, Connors KA, Davoli KA, McMillen CM, et al
    Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
    J Virol. 2022;96:e0111222.
    PubMed     Abstract available
    
    
    
12. ZHONG Y, Wu C, Xu Z, Teng Y, et al
    Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    J Virol. 2022 Oct 13:e0136222. doi: 10.1128/jvi.01362.
    PubMed     Abstract available
    
    
    September 2022
13. LIU Y, Kornyeyev D, May L, Han D, et al
    Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.
    J Virol. 2022;96:e0084922.
    PubMed     Abstract available
    
    
    
14. KIM GW, Moon JS, Gudima SO, Siddiqui A, et al
    N(6)-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1.
    J Virol. 2022 Sep 14:e0112422. doi: 10.1128/jvi.01124.
    PubMed     Abstract available
    
    
    
15. SOORYANARAIN H, Heffron CL, Mahsoub HM, Hassebroek AM, et al
    Modulation of SOCS3 Levels via STAT3 and Estrogen-ERalphap66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells.
    J Virol. 2022 Sep 14:e0100822. doi: 10.1128/jvi.01008.
    PubMed     Abstract available
    
    
    August 2022
16. SASAKI-TANAKA R, Shibata T, Moriyama M, Okamoto H, et al
    Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
    J Virol. 2022 Aug 30:e0064622. doi: 10.1128/jvi.00646.
    PubMed     Abstract available
    
    
    
17. JIANG J, Hao Y, He B, Su L, et al
    Severe Acute Hepatitis Outbreaks Associated with a Novel Hepacivirus in Rhizomys pruinosus in Hainan, China.
    J Virol. 2022 Aug 25:e0078222. doi: 10.1128/jvi.00782.
    PubMed     Abstract available
    
    
    
18. ROGIER E, Plucinski M, Candrinho B, Moss DM, et al
    Adaptation to a Multiplex Bead Assay and Seroprevalence to Rift Valley Fever N Protein: Nampula Province, Mozambique, 2013-2014.
    J Virol. 2022;96:e0067222.
    PubMed     Abstract available
    
    
    
19. WANG XQ, Zerbato JM, Avihingsanon A, Fisher K, et al
    Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
    J Virol. 2022 Aug 2:e0058822. doi: 10.1128/jvi.00588.
    PubMed     Abstract available
    
    
    July 2022
20. HONG X, Hu J
    Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.
    J Virol. 2022 Jul 18:e0071822. doi: 10.1128/jvi.00718.
    PubMed     Abstract available
    
    
    
21. CHEN Y, Yao Y, Zhao K, Liu C, et al
    DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    J Virol. 2022;96:e0058522.
    PubMed     Abstract available
    
    
    June 2022
22. WU Q, Zhang L, Xu X, Zhang Y, et al
    Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
    J Virol. 2022 Jun 13:e0061122. doi: 10.1128/jvi.00611.
    PubMed     Abstract available
    
    
    
23. LI Y, He M, Gong R, Wang Z, et al
    Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Inter
    J Virol. 2022 Jun 13:e0054622. doi: 10.1128/jvi.00546.
    PubMed     Abstract available
    
    
    May 2022
24. VIJAYAMAHANTESH V, Patra T, Meyer K, Alameh MG, et al
    Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response.
    J Virol. 2022 May 25:e0052322. doi: 10.1128/jvi.00523.
    PubMed     Abstract available
    
    
    April 2022
25. PLEY C, Lourenco J, McNaughton AL, Matthews PC, et al
    Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
    J Virol. 2022 Apr 12:e0005122. doi: 10.1128/jvi.00051.
    PubMed     Abstract available
    
    
    
26. XI J, Cui X, Liu K, Liu H, et al
    Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.
    J Virol. 2022 Apr 7:e0039922. doi: 10.1128/jvi.00399.
    PubMed     Abstract available
    
    
    March 2022
27. WAN H, Adams RL, Lindenbach BD, Pyle AM, et al
    The In Vivo and In Vitro Architecture of the Hepatitis C Virus RNA Genome Uncovers Functional RNA Secondary and Tertiary Structures.
    J Virol. 2022 Mar 30:e0194621. doi: 10.1128/jvi.01946.
    PubMed     Abstract available
    
    
    
28. REINECKE B, Frericks N, Lauber C, Dinkelborg K, et al
    The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
    J Virol. 2022 Mar 17:e0199521. doi: 10.1128/jvi.01995.
    PubMed     Abstract available
    
    
    
29. YU CC, Lin PC, Chiang CH, Jen ST, et al
    Sequential Phosphorylation of Hepatitis C Virus NS5A Protein Requires the ATP-Binding Domain of NS3 Helicase.
    J Virol. 2022 Mar 16:e0010722. doi: 10.1128/jvi.00107.
    PubMed     Abstract available
    
    
    
30. TAKEMORI T, Sugimoto-Ishige A, Nishitsuji H, Futamura Y, et al
    Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    J Virol. 2022;96:e0168621.
    PubMed     Abstract available
    
    
    February 2022
31. PRIMADHARSINI PP, Nagashima S, Nishiyama T, Takahashi M, et al
    Development of recombinant infectious hepatitis E virus harboring the nanoKAZ gene and its application in drug screening.
    J Virol. 2022 Feb 2:jvi0190621. doi: 10.1128/jvi.01906.
    PubMed     Abstract available
    
    
    January 2022
32. KIM C, Barnes LF, Schlicksup CJ, Patterson AJ, et al
    Core Protein-Directed Antivirals and Importin beta Can Synergistically Disrupt Hepatitis B Virus Capsids.
    J Virol. 2022;96:e0139521.
    PubMed     Abstract available
    
    
    
33. MARCHETTI AL, Zhang H, Kim ES, Yu X, et al
    Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    J Virol. 2022;96:e0136021.
    PubMed     Abstract available
    
    
    
34. DENG L, Liang Y, Ariffianto A, Matsui C, et al
    Hepatitis C virus (HCV)-induced ROS/JNK signaling pathway activates the E3 ubiquitin ligase Itch to promote the release of HCV particles via polyubiquitylation of VPS4A.
    J Virol. 2022 Jan 19:JVI0181121. doi: 10.1128/JVI.01811.
    PubMed     Abstract available
    
    
    
35. ZHANG J, Yuan Q, Wang Y, Wang Y, et al
    5' preS1 mutations to prevent large envelope protein expression from hepatitis B virus genotype A or genotype D markedly increase polymerase-envelope fusion protein.
    J Virol. 2022 Jan 12:JVI0172321. doi: 10.1128/JVI.01723.
    PubMed     Abstract available
    
    
    
36. MCGREGOR J, Hardy JM, Lay CS, Boo I, et al
    Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    J Virol. 2022 Jan 5:JVI0167521. doi: 10.1128/JVI.01675.
    PubMed     Abstract available
    
    
    December 2021
37. WU SX, Ye SS, Hong YX, Chen Y, et al
    Hepatitis B virus small envelope protein promotes HCC angiogenesis via ER stress signaling to upregulate VEGFA expression.
    J Virol. 2021 Dec 15:JVI0197521. doi: 10.1128/JVI.01975.
    PubMed     Abstract available
    
    
    
38. PANIGRAHI M, Thibault PA, Wilson JA
    miR-122 affects both the initiation and maintenance of Hepatitis C Virus infections.
    J Virol. 2021 Dec 15:JVI0190321. doi: 10.1128/JVI.01903.
    PubMed     Abstract available
    
    
    
39. STEPHENSON-TSORIS S, Casey JL
    Hepatitis delta virus genome RNA synthesis initiates at position 1646 with a non-templated guanosine.
    J Virol. 2021 Dec 8:JVI0201721. doi: 10.1128/JVI.02017.
    PubMed     Abstract available
    
    
    
40. KIM GW, Siddiqui A
    Hepatitis B virus X (HBx) Protein Expression is Tightly Regulated by N6-methyladenosine Modification of its mRNA.
    J Virol. 2021 Dec 1:JVI0165521. doi: 10.1128/JVI.01655.
    PubMed     Abstract available
    
    
    November 2021
41. BARBEAU DJ, Cartwright HN, Harmon JR, Spengler JR, et al
    Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
    J Virol. 2021;95:e0150621.
    PubMed     Abstract available
    
    
    
42. KHATUN M, Kumar K, Baidya A, Mondal RK, et al
    Variability in the response of HBV D-subgenotypes to antiviral therapy: designing pan D-subgenotypic reverse transcriptase inhibitors.
    J Virol. 2021 Nov 3:JVI0180021. doi: 10.1128/JVI.01800.
    PubMed     Abstract available
    
    
    October 2021
43. XI J, Liu H, Hu J
    Regulation of Hepatitis B Virus Virion Release and Envelopment Timing by Nucleocapsid and Envelope Interactions.
    J Virol. 2021 Oct 13:JVI0130521. doi: 10.1128/JVI.01305.
    PubMed     Abstract available
    
    
    
44. FUKANO K, Oshima M, Tsukuda S, Aizaki H, et al
    NTCP oligomerization occurs downstream of the NTCP-EGFR interaction during hepatitis B virus internalization.
    J Virol. 2021 Oct 6:JVI0093821. doi: 10.1128/JVI.00938.
    PubMed     Abstract available
    
    
    September 2021
45. ZOU S, Du Y, Huang S, Chen M, et al
    Simultaneous or prior activation of intrahepatic type I interferon signaling leads to hepatitis B virus persistence in a mouse model.
    J Virol. 2021 Sep 22:e0003421. doi: 10.1128/JVI.00034.
    PubMed     Abstract available
    
    
    
46. SARI G, Zhu J, Ambardekar C, Yin X, et al
    The viral ORF3 protein is required for hepatitis E virus apical release and efficient growth in polarized hepatocytes and humanized mice.
    J Virol. 2021 Sep 15:JVI0058521. doi: 10.1128/JVI.00585.
    PubMed     Abstract available
    
    
    
47. RAMIREZ R, van Buuren N, Gamelin L, Soulette C, et al
    Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
    J Virol. 2021;95:e0029921.
    PubMed     Abstract available
    
    
    July 2021
48. TARNOW G, McLachlan A
    B-Catenin Signaling Regulates the In Vivo Distribution of Hepatitis B Virus Biosynthesis across the Liver Lobule.
    J Virol. 2021 Jul 28:JVI0078021. doi: 10.1128/JVI.00780.
    PubMed     Abstract available
    
    
    
49. MAO R, Dong M, Shen Z, Zhang H, et al
    RNA Helicase DDX17 inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
    J Virol. 2021 Jul 21:JVI0044421. doi: 10.1128/JVI.00444.
    PubMed     Abstract available
    
    
    June 2021
50. LIU F, Lee ACH, Guo F, Kondratowicz AS, et al
    Host poly(A) polymerases PAPD5 and PAPD7 provide two layers of protection that ensure the integrity and stability of hepatitis B virus RNA.
    J Virol. 2021 Jun 30:JVI0057421. doi: 10.1128/JVI.00574.
    PubMed     Abstract available
    
    
    
51. KHATUN M, Zhang J, Ray R, Ray RB, et al
    Hepatitis C virus evades IFN signaling by suppressing long non-coding RNA Linc-Pint involving c/EBP-beta.
    J Virol. 2021 Jun 23:JVI0095221. doi: 10.1128/JVI.00952.
    PubMed     Abstract available
    
    
    
52. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    PubMed     Abstract available
    
    
    May 2021
53. LIU H, Xi J, Hu J
    Regulation of Hepatitis B Virus Replication by Cyclin Docking Motifs in Core Protein.
    J Virol. 2021;95.
    PubMed     Abstract available
    
    
    
54. VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
    Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
    J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
    PubMed     Abstract available
    
    
    
55. IBRAHIM MK, Abdelhafez TH, Takeuchi JS, Wakae K, et al
    MafF is an antiviral host factor that suppresses transcription from Hepatitis B Virus core promoter.
    J Virol. 2021 May 12. pii: JVI.00767-21. doi: 10.1128/JVI.00767.
    PubMed     Abstract available
    
    
    
56. MISUMI I, Li Z, Sun L, Das A, et al
    Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Ifnar1(-/-) Mice.
    J Virol. 2021;95:e0005821.
    PubMed     Abstract available
    
    
    April 2021
57. FU S, Zhang J, Yuan Q, Wang Q, et al
    Lost small envelope protein expression from naturally occurring preS1 deletion mutants of hepatitis B virus is often accompanied by increased HBx and core protein expression as well as genome replication.
    J Virol. 2021 Apr 28. pii: JVI.00660-21. doi: 10.1128/JVI.00660.
    PubMed     Abstract available
    
    
    
58. REINHARZ V, Ishida Y, Tsuge M, Durso-Cain K, et al
    Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice.
    J Virol. 2021 Apr 28. pii: JVI.00492-20. doi: 10.1128/JVI.00492.
    PubMed     Abstract available
    
    
    
59. KIM GW, Imam H, Siddiqui A
    The RNA binding proteins YTHDC1 and FMRP regulate the nuclear export of N6-methyladenosine modified Hepatitis B Virus transcripts and affect the viral life cycle.
    J Virol. 2021 Apr 21. pii: JVI.00097-21. doi: 10.1128/JVI.00097.
    PubMed     Abstract available
    
    
    
60. MCMILLEN CM, Hartman AL
    Rift Valley Fever: a Threat to Pregnant Women Hiding in Plain Sight?
    J Virol. 2021;95.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: